EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
Abstract
The article describes the therapy for atopic dermatitis with topical glucocorticosteroids. Parameters of the «ideal» topical cortico steroid are provided: strong anti-inflammatory effect, low systemic bioavailability, quick action onset, minimal side effects, multiplicity of pharmaceutical forms. It describes results of a number of clinical trials for efficacy and safety of using mometasone furoate in children, a pharmaceutical product close enough to the «ideal» characteristics of a topical corticosteroid.
Key words: atopic dermatitis, topical glucocorticosteroids, mometasone furoate, children, safety.
Key words: atopic dermatitis, topical glucocorticosteroids, mometasone furoate, children, safety.
About the Authors
A.Yu. Tomilova
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
R.M. Torshkhoeva
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A.K. Gevorkyan
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
N.I. Voznesenskaya
Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Tomilova A., Torshkhoeva R., Gevorkyan A., Voznesenskaya N. EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS. Pediatric pharmacology. 2009;6(4):123-127.
Views:
768
Email this article 